Organization and Business Description (Tables)

12 Months Ended

Sep. 30, 2025

Organization and Business Description [Line Items]

Schedule of Consolidated Financial Statements of the Company

The consolidated financial statements of the Company include the following entities:

Name of Entity	Date of Incorporation	Place of Incorporation	% of Ownership		Principal Activities
Jin Med	January 14, 2020	Cayman Island		Parent	Investment holding
Zhongjin HK	February 25, 2020	Hong Kong		100%	Investment holding
Erhua Med	September 24, 2020	PRC		100%	WFOE, Investment holding
Changzhou Zhongjin	January 26, 2006	PRC		VIE	Design, development, manufacturing and sales of wheelchair and other mobility products
Taizhou Zhongjin	June 17, 2013	PRC		100% controlled subsidiary of the VIE	Design, development, manufacturing and sales of wheelchair and other mobility products
Zhongjin Jing’ao	December 18, 2014	PRC		100% controlled subsidiary of the VIE	Design, development, manufacturing and sales of wheelchair and other mobility products
Zhongjin Kangma	August 21, 2023	PRC		80% controlled subsidiary of the VIE	Sales of wheelchair and other mobility products
Anhui Zhongjin	October 7, 2023	PRC		100%	Not in operation yet
Zhongjin Kangma Health	February 19, 2025	PRC		100% controlled subsidiary of the Zhongjin Kangma	Newly incorporated – not in operation yet
Guangxi Zhongjin	December 11, 2025	PRC		100%	Newly incorporated – not in operation yet

VIE [Member]

Organization and Business Description [Line Items]

Schedule of Financial Statement Amounts and Balances of the VIE and VIE’s Subsidiaries

The following financial statement amounts and balances of the VIE and VIE’s subsidiaries were included in the accompanying consolidated financial statements after elimination of intercompany transactions and balances:

	September 30, 2025		September 30, 2024
Current assets	$	38,865,435	$	37,842,016
Non-current assets		1,622,787		1,971,681
Total assets	$	40,488,222	$	39,813,697
Current liabilities	$	23,438,856	$	17,013,879
Non-current liabilities		-		96,175
Total liabilities	$	23,438,856	$	17,110,054

Schedule of Revenue

	For the Years Ended September 30,
	2025		2024		2023
Net revenue	$	20,687,274	$	23,502,010	$	19,821,457
Net income	$	1,727,900	$	4,508,981	$	3,438,466

Schedule of Cash Flow Statement

	For the Years Ended September 30,
	2025			2024			2023
Net cash provided by operating activities	$	3,637,903		$	65,036		$	3,566,639
Net cash used in investing activities		(11,250,161	)		(9,370,058	)		(2,430,248	)
Net cash provided by (used in) financing activities	$	7,353,231		$	11,204,749		$	(213,892	)